Comparison between Endoscopic Ultrasound‐Guided Antegrade and Transluminal Stent Implantation in Distal Malignant Biliary Obstruction after Failed ERCP
Gastroenterology Research and Practice · 2024-01 · 2024 (1)
DOI: 10.1155/2024/1458297 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gastroenterology Research and Practice, online erschienen am 14.05.2024. Verfasst von Yonghua Shen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nanjing University.
Abstract (Originalsprache)
Background
Distal malignant biliary obstruction (DMBO) can result in obstructive jaundice. Endoscopic ultrasound‐ (EUS‐) guided biliary drainage (EUS‐BD) has been an alternative for DMBO after failed ERCP.
Aim
To compare the efficacy and safety between antegrade and transluminal approaches in patients with unresectable DMBO when ERCP failed.
Methods
Patients with DMBO leading to obstructive jaundice after failed ERCP were enrolled in this study. We retrospectively evaluated the safety and efficacy between EUS‐guided transluminal stenting (TLS group) and antegrade stenting (AGS group).
Results
82 patients were enrolled, of which 45 patients were in TLS group and 37 in AGS group. There were no statistical differences in the malignancy type, baseline common bile duct diameter, total bilirubin level, reason for EUS‐BD, and history of biliary drainage between TLS and AGS groups. The technical success rate was statistically higher in TLS group than in AGS group (97.8 vs. 81.1%, P = 0.031). There were no statistical differences in clinical success rate, procedure‐related adverse events, stent migration rate, stent dysfunction rate, reintervention rate, and overall patient survival time between TLS and AGS groups. The median time to stent dysfunction or patient death in TLS and AGS groups was 53 and 81 days, respectively ( P = 0.017).
Conclusions
Although AGS had a lower technical success rate than TLS, it was superior to TLS in stent patency in patients with DMBO.
Autor:innen und Institutionen
- Department of Gastroenterology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
- Biliopancreatic Endoscopic Surgery Department, Second Hospital of Hebei Medical University, Shijiazhuang, China.
ORCID-Profile: Yonghua Shen, Ying Lv, Xiaojiao Zheng, Wei Zhan, Senlin Hou, Lin Zhou, Jun Cao, Bin Zhang, Lei Wang, Hao Zhu, Lichao Zhang
Förderung
- Nanjing University
Zitieren
APA
Shen, Y., Lv, Y., Zheng, X., Zhan, W., Hou, S., Zhou, L., Cao, J., Zhang, B., Wang, L., Zhu, H., & Zhang, L. (2024). Comparison between Endoscopic Ultrasound‐Guided Antegrade and Transluminal Stent Implantation in Distal Malignant Biliary Obstruction after Failed ERCP. Gastroenterology Research and Practice, 2024(1). https://doi.org/10.1155/2024/1458297
Vancouver
Shen Y, Lv Y, Zheng X, Zhan W, Hou S, Zhou L, et al. Comparison between Endoscopic Ultrasound‐Guided Antegrade and Transluminal Stent Implantation in Distal Malignant Biliary Obstruction after Failed ERCP. Gastroenterology Research and Practice. 2024;2024(1). doi:10.1155/2024/1458297
BibTeX
@article{Shen2024,
author = {Shen, Yonghua and Lv, Ying and Zheng, Xiaojiao and Zhan, Wei and Hou, Senlin and Zhou, Lin and Cao, Jun and Zhang, Bin and Wang, Lei and Zhu, Hao and Zhang, Lichao},
title = {Comparison between Endoscopic Ultrasound‐Guided Antegrade and Transluminal Stent Implantation in Distal Malignant Biliary Obstruction after Failed ERCP},
journal = {Gastroenterology Research and Practice},
year = {2024},
volume = {2024},
number = {1},
doi = {10.1155/2024/1458297}
}
EUVIMED